SIYLA LIMITED

Company number 13909371 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SIYLA LIMITED - Analysis Report

Company Number: 13909371

Analysis Date: 2025-07-20 18:35 UTC

Financial Health Assessment for SIYLA LIMITED as at 28 February 2024


1. Financial Health Score: Grade D

Explanation:
SIYLA LIMITED exhibits critical warning signs of financial distress. The company’s net current assets and net assets are significantly negative, indicating severe liquidity and solvency issues. While it is an active micro-entity with minimal filing requirements, the financial "vital signs" suggest an unhealthy financial condition that requires urgent attention.


2. Key Vital Signs

Metric Value (£) Interpretation
Current Assets 17 Extremely low liquid assets; virtually no cash or receivables to cover short-term debts.
Current Liabilities 64,924 High short-term obligations; company owes substantially more than it holds in liquid assets.
Net Current Assets (Working Capital) -64,907 Negative working capital indicates inability to meet short-term debts as they fall due.
Fixed Assets 31,275 Tangible or intangible long-term assets exist, but these may not readily convert to cash.
Net Assets (Shareholders’ Funds) -33,831 Negative equity means liabilities exceed total assets, a critical financial "symptom."
Called-Up Share Capital Not Paid 100 Minor unpaid capital, insignificant impact on financial health.
Employees 0 No staff employed, suggesting low operational activity or early stage of business.

3. Diagnosis

The company’s financial "vital signs" reveal symptoms of serious financial distress:

  • Liquidity Crisis: With only £17 in current assets against nearly £65,000 in current liabilities, SIYLA LIMITED has a dangerously unhealthy cash flow position. This is akin to a patient with almost no blood supply to vital organs—there is insufficient liquid resource to meet immediate obligations.

  • Solvency Concerns: Negative net assets of £33,831 indicate the company owes more than it owns. This is a classic symptom of insolvency risk, threatening the company’s ability to continue as a going concern without fresh capital or restructuring.

  • Asset Base: Fixed assets of £31,275 present some value, but these are likely illiquid and cannot be quickly converted to cash to relieve short-term pressure.

  • Operational Status: No employees and minimal current assets suggest the company may be in a nascent stage or dormant operationally, yet it carries significant liabilities, possibly from loans or payables.

  • Stability: The financial position has not improved over the past two years (2022 and 2023 data identical), indicating persistent lack of recovery or growth.

Overall, the company is exhibiting symptoms of financial "illness" that, if untreated, could lead to failure or insolvency.


4. Recommendations

To improve SIYLA LIMITED’s financial wellness, consider the following specific actions:

  1. Inject Fresh Capital:
    Immediate equity injection or shareholder loans are needed to restore positive net assets and strengthen the balance sheet.

  2. Restructure Liabilities:
    Negotiate with creditors to extend payment terms or reduce liabilities to alleviate short-term cash flow pressure.

  3. Enhance Cash Flow Management:
    Develop a rigorous cash flow forecast and management system to monitor and control outflows and inflows closely.

  4. Asset Review and Monetization:
    Evaluate fixed assets for potential sale or leveraging to raise cash quickly.

  5. Operational Review:
    Given zero employees, clarify the business model and operational plans to generate revenues and improve liquidity.

  6. Professional Advice:
    Engage insolvency or restructuring professionals early to explore recovery options and avoid formal insolvency procedures.


Executive Summary

SIYLA LIMITED is currently in a financially distressed state, with critically low liquidity and negative net assets indicating insolvency risk. Without immediate capital injection and liability restructuring, the company faces significant challenges to its survival. Prompt action to improve cash flow and reduce debts is essential for recovery.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.